Search - tctmd.com

Displaying 341 - 360 of 389

Sort: Relevancy | Date

News Industry News

Edwards Lifesciences heart valve study halted

November 08, 2011

News Industry News

First Research Results of Angiomax(R) (Bivalirudin) Versus Heparin in Transcatheter Aortic Valve Interventions Reported at TCT

November 07, 2011

News Industry News

CoreValve gets CE Mark, FDA grants PARTNER II extension

November 07, 2011

News Industry News

Boston Scientific Carotid WALLSTENT® Found Safe in Study of High Surgical Risk Patients in Routine Clinical Practice

November 07, 2011

News Industry News

Virmani's crystal ball: Transcatheter valves

November 06, 2011

News Industry News

Real-World TAVI Results Mirror Clinical Trials

November 06, 2011

News Industry News

Edwards Receives FDA Approval to Expand U.S. Clinical Trial of Next-Generation Transcatheter Valve

November 06, 2011

News Industry News

Sunshine Heart Announces Results of Its C-Pulse(R) Feasibility Trial at the Transcatheter Cardiovascular Therapeutics Conference

November 06, 2011

News Industry News

FDA Approves XARELTO® (rivaroxaban) to Reduce the Risk of Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation

November 04, 2011

News Industry News

FDA approves first artificial aortic heart valve placed without open-heart surgery

November 02, 2011

News Industry News

Emboline, Inc. to Debut Game-Changing Embolic Protection Technology for Percutaneous Heart Valve Procedures in San Francisco Next Week

November 02, 2011

News Industry News

Medtronic Starts Landmark Study of Hypertension Treatment

October 26, 2011

News Industry News

Data Published in Circulation Journal Show OrbusNeich's GenousTM Stent Is Safe and Effective in Elderly Patients

October 25, 2011

News Industry News

Medtronic Announces Results From TTOP-AF Trial Demonstrating Clinical Benefits of Its Phased RF Ablation System in Treating Persistent Atrial Fibrillation

October 10, 2011

News Industry News

Bayer AG: Phase III Study of Bayer’s Rivaroxaban in Patients with Acute Coronary Syndrome Meets Primary Efficacy Endpoint

September 29, 2011

News Industry News

FDA Advisory Committee Recommends Approval of Oral Anticoagulant Rivaroxaban for the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation

September 08, 2011

News Industry News

Effient® (Prasugrel) Showed Significant 26 Percent Reduction in Cardiovascular Events Over Clopidogrel in New Core Clinical Cohort Population Sub-Analysis of the TRITON-TIMI 38 Pivotal Study

August 15, 2011

News Industry News

Abbott Receives U.S. FDA Approval for RX Herculink Elite® Renal Stent System for Treatment of Renal Artery Disease

August 10, 2011

News Industry News

First Patient Enrolls in St. Jude Medical Supported Landmark Study Investigating Atrial Fibrillation Treatment Options

August 02, 2011

News Industry News

FDA Approves New Medicine BRILINTA™ (Ticagrelor) for Use in the US

July 20, 2011

Advertisement

Edwards Lifesciences heart valve study halted

First Research Results of Angiomax(R) (Bivalirudin) Versus Heparin in Transcatheter Aortic Valve Interventions Reported at TCT

CoreValve gets CE Mark, FDA grants PARTNER II extension

Boston Scientific Carotid WALLSTENT® Found Safe in Study of High Surgical Risk Patients in Routine Clinical Practice

Virmani's crystal ball: Transcatheter valves

Real-World TAVI Results Mirror Clinical Trials

Edwards Receives FDA Approval to Expand U.S. Clinical Trial of Next-Generation Transcatheter Valve

Sunshine Heart Announces Results of Its C-Pulse(R) Feasibility Trial at the Transcatheter Cardiovascular Therapeutics Conference

FDA Approves XARELTO® (rivaroxaban) to Reduce the Risk of Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation

FDA approves first artificial aortic heart valve placed without open-heart surgery

Emboline, Inc. to Debut Game-Changing Embolic Protection Technology for Percutaneous Heart Valve Procedures in San Francisco Next Week

Medtronic Starts Landmark Study of Hypertension Treatment

Data Published in Circulation Journal Show OrbusNeich's GenousTM Stent Is Safe and Effective in Elderly Patients

Medtronic Announces Results From TTOP-AF Trial Demonstrating Clinical Benefits of Its Phased RF Ablation System in Treating Persistent Atrial Fibrillation

Bayer AG: Phase III Study of Bayer’s Rivaroxaban in Patients with Acute Coronary Syndrome Meets Primary Efficacy Endpoint

FDA Advisory Committee Recommends Approval of Oral Anticoagulant Rivaroxaban for the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation

Effient® (Prasugrel) Showed Significant 26 Percent Reduction in Cardiovascular Events Over Clopidogrel in New Core Clinical Cohort Population Sub-Analysis of the TRITON-TIMI 38 Pivotal Study

Abbott Receives U.S. FDA Approval for RX Herculink Elite® Renal Stent System for Treatment of Renal Artery Disease

First Patient Enrolls in St. Jude Medical Supported Landmark Study Investigating Atrial Fibrillation Treatment Options

FDA Approves New Medicine BRILINTA™ (Ticagrelor) for Use in the US

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content